Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients - PubMed (original) (raw)
Clinical Trial
. 2003 Aug 1;102(3):1121-30.
doi: 10.1182/blood-2002-08-2545. Epub 2003 Apr 17.
Marcella Sarzotti, Daniel A Ozaki, Gregory D Sempowski, Maria E Rhein, Laura P Hale, Francoise Le Deist, Marilyn J Alexieff, Jie Li, Elizabeth R Hauser, Barton F Haynes, Henry E Rice, Michael A Skinner, Samuel M Mahaffey, James Jaggers, Leonard D Stein, Michael R Mill
Affiliations
- PMID: 12702512
- DOI: 10.1182/blood-2002-08-2545
Free article
Clinical Trial
Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients
M Louise Markert et al. Blood. 2003.
Free article
Abstract
Complete DiGeorge syndrome is a fatal condition in which infants have no detectable thymus function. The optimal treatment for the immune deficiency of complete DiGeorge syndrome has not been determined. Safety and efficacy of thymus transplantation were evaluated in 12 infants with complete DiGeorge syndrome who had less than 20-fold proliferative responses to phytohemagglutinin. All but one had fewer than 50 T cells/mm3. Allogeneic postnatal cultured thymus tissue was transplanted. T-cell development was followed by flow cytometry, lymphocyte proliferation assays, and T-cell receptor Vbeta (TCRBV) repertoire evaluation. Of the 12 patients, 7 are at home 15 months to 8.5 years after transplantation. All 7 survivors developed T-cell proliferative responses to mitogens of more than 100 000 counts per minute (cpm). By one year after transplantation, 6 of 7 patients developed antigen-specific proliferative responses. The TCRBV repertoire showed initial oligoclonality that progressed to polyclonality within a year. B-cell function developed in all 3 patients tested after 2 years. Deaths were associated with underlying congenital problems. Risk factors for death included tracheostomy, long-term mechanical ventilation, and cytomegalovirus infection. Adverse events in the first 3 months after transplantation included eosinophilia, rash, lymphadenopathy, development of CD4-CD8- peripheral T cells, elevated serum immunoglobulin E (IgE), and possible pulmonary inflammation. Adverse events related to the immune system occurring more than 3 months after transplantation included thrombocytopenia in one patient and hypothyroidism and alopecia in one other patient. Thymic transplantation is efficacious, well tolerated, and should be considered as treatment for infants with complete DiGeorge syndrome.
Similar articles
- Transplantation of thymus tissue in complete DiGeorge syndrome.
Markert ML, Boeck A, Hale LP, Kloster AL, McLaughlin TM, Batchvarova MN, Douek DC, Koup RA, Kostyu DD, Ward FE, Rice HE, Mahaffey SM, Schiff SE, Buckley RH, Haynes BF. Markert ML, et al. N Engl J Med. 1999 Oct 14;341(16):1180-9. doi: 10.1056/NEJM199910143411603. N Engl J Med. 1999. PMID: 10523153 Clinical Trial. - Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome.
Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH, Sedlak DA, Sempowski GD, Hale LP, Rice HE, Mahaffey SM, Skinner MA. Markert ML, et al. Blood. 2004 Oct 15;104(8):2574-81. doi: 10.1182/blood-2003-08-2984. Epub 2004 Apr 20. Blood. 2004. PMID: 15100156 Clinical Trial. - Thymus transplantation for complete DiGeorge syndrome: European experience.
Davies EG, Cheung M, Gilmour K, Maimaris J, Curry J, Furmanski A, Sebire N, Halliday N, Mengrelis K, Adams S, Bernatoniene J, Bremner R, Browning M, Devlin B, Erichsen HC, Gaspar HB, Hutchison L, Ip W, Ifversen M, Leahy TR, McCarthy E, Moshous D, Neuling K, Pac M, Papadopol A, Parsley KL, Poliani L, Ricciardelli I, Sansom DM, Voor T, Worth A, Crompton T, Markert ML, Thrasher AJ. Davies EG, et al. J Allergy Clin Immunol. 2017 Dec;140(6):1660-1670.e16. doi: 10.1016/j.jaci.2017.03.020. Epub 2017 Apr 8. J Allergy Clin Immunol. 2017. PMID: 28400115 Free PMC article. - Thymus transplantation.
Markert ML, Devlin BH, McCarthy EA. Markert ML, et al. Clin Immunol. 2010 May;135(2):236-46. doi: 10.1016/j.clim.2010.02.007. Epub 2010 Mar 16. Clin Immunol. 2010. PMID: 20236866 Free PMC article. Review. - Replacing defective thymus function.
Kreins AY, Graham Davies E. Kreins AY, et al. Curr Opin Allergy Clin Immunol. 2020 Dec;20(6):541-548. doi: 10.1097/ACI.0000000000000695. Curr Opin Allergy Clin Immunol. 2020. PMID: 33044341 Review.
Cited by
- Site-specific development and progressive maturation of human tissue-resident memory T cells over infancy and childhood.
Connors TJ, Matsumoto R, Verma S, Szabo PA, Guyer R, Gray J, Wang Z, Thapa P, Dogra P, Poon MML, Rybkina K, Bradley MC, Idzikowski E, McNichols J, Kubota M, Pethe K, Shen Y, Atkinson MA, Brusko M, Brusko TM, Yates AJ, Sims PA, Farber DL. Connors TJ, et al. Immunity. 2023 Aug 8;56(8):1894-1909.e5. doi: 10.1016/j.immuni.2023.06.008. Epub 2023 Jul 7. Immunity. 2023. PMID: 37421943 Free PMC article. - Congenital Athymia: Unmet Needs and Practical Guidance.
Howley E, Davies EG, Kreins AY. Howley E, et al. Ther Clin Risk Manag. 2023 Mar 13;19:239-254. doi: 10.2147/TCRM.S379673. eCollection 2023. Ther Clin Risk Manag. 2023. PMID: 36935770 Free PMC article. Review. - Case Report: Nontuberculous mycobacterial infections in children with complete DiGeorge anomaly.
Hicks ED, Agada NO, Yates TR, Kelly MS, Tam JS, Ferdman RM, Dibernardo LR, Madden JF, Moody MA, Markert ML. Hicks ED, et al. Front Immunol. 2023 Feb 13;14:1078976. doi: 10.3389/fimmu.2023.1078976. eCollection 2023. Front Immunol. 2023. PMID: 36860874 Free PMC article. - Generation of functional human T cell development in NOD/SCID/IL2rγnull humanized mice without using fetal tissue: Application as a model of HIV infection and persistence.
Colas C, Volodina O, Béland K, Pham TNQ, Li Y, Dallaire F, Soulard C, Lemieux W, Colamartino ABL, Tremblay-Laganière C, Dicaire R, Guimond J, Vobecky S, Poirier N, Patey N, Cohen ÉA, Haddad E. Colas C, et al. Stem Cell Reports. 2023 Feb 14;18(2):597-612. doi: 10.1016/j.stemcr.2023.01.003. Epub 2023 Feb 2. Stem Cell Reports. 2023. PMID: 36736326 Free PMC article. - Experience with cultured thymus tissue in 105 children.
Markert ML, Gupton SE, McCarthy EA. Markert ML, et al. J Allergy Clin Immunol. 2022 Feb;149(2):747-757. doi: 10.1016/j.jaci.2021.06.028. Epub 2021 Aug 4. J Allergy Clin Immunol. 2022. PMID: 34362576 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials